LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 240

Search options

  1. Article ; Online: T-cell help in the germinal center: homing in on the role of IL-21.

    Petersone, Lina / Walker, Lucy S K

    International immunology

    2024  Volume 36, Issue 3, Page(s) 89–98

    Abstract: Interleukin 21 (IL-21) is a pleiotropic cytokine that is overproduced in multiple autoimmune settings. Provision of IL-21 from follicular helper T cells is an important component of T-cell help within germinal centers (GC), and the last few years have ... ...

    Abstract Interleukin 21 (IL-21) is a pleiotropic cytokine that is overproduced in multiple autoimmune settings. Provision of IL-21 from follicular helper T cells is an important component of T-cell help within germinal centers (GC), and the last few years have seen a resurgence of interest in IL-21 biology in the context of the GC environment. While it has been more than a decade since T cell-derived IL-21 was found to upregulate B-cell expression of the GC master transcription factor B-cell lymphoma 6 (Bcl-6) and to promote GC expansion, several recent studies have collectively delivered significant new insights into how this cytokine shapes GC B-cell selection, proliferation, and fate choice. It is now clear that IL-21 plays an important role in GC zonal polarization by contributing to light zone GC B-cell positive selection for dark zone entry as well as by promoting cyclin D3-dependent dark zone inertial cycling. While it has been established that IL-21 can contribute to the modulation of GC output by aiding the generation of antibody-secreting cells (ASC), recent studies have now revealed how IL-21 signal strength shapes the fate choice between GC cycle re-entry and ASC differentiation in vivo. Both provision of IL-21 and sensitivity to this cytokine are finely tuned within the GC environment, and dysregulation of this pathway in autoimmune settings could alter the threshold for germinal center B-cell selection and differentiation, potentially promoting autoreactive B-cell responses.
    MeSH term(s) T-Lymphocytes, Helper-Inducer ; Germinal Center ; Interleukins ; B-Lymphocytes ; Cell Differentiation
    Chemical Substances interleukin-21 (MKM3CA6LT1) ; Interleukins
    Language English
    Publishing date 2024-02-22
    Publishing country England
    Document type Journal Article
    ZDB-ID 1013745-2
    ISSN 1460-2377 ; 0953-8178
    ISSN (online) 1460-2377
    ISSN 0953-8178
    DOI 10.1093/intimm/dxad056
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The link between circulating follicular helper T cells and autoimmunity.

    Walker, Lucy S K

    Nature reviews. Immunology

    2022  Volume 22, Issue 9, Page(s) 567–575

    Abstract: Follicular helper T ( ... ...

    Abstract Follicular helper T (T
    MeSH term(s) Autoimmune Diseases ; Autoimmunity ; Cell Differentiation ; Germinal Center ; Humans ; T Follicular Helper Cells ; T-Lymphocytes, Helper-Inducer
    Language English
    Publishing date 2022-03-11
    Publishing country England
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2062776-2
    ISSN 1474-1741 ; 1474-1733
    ISSN (online) 1474-1741
    ISSN 1474-1733
    DOI 10.1038/s41577-022-00693-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Type 1 diabetes.

    Quattrin, Teresa / Mastrandrea, Lucy D / Walker, Lucy S K

    Lancet (London, England)

    2023  Volume 401, Issue 10394, Page(s) 2149–2162

    Abstract: Type 1 diabetes is a chronic disease caused by autoimmune destruction of pancreatic β cells. Individuals with type 1 diabetes are reliant on insulin for survival. Despite enhanced knowledge related to the pathophysiology of the disease, including ... ...

    Abstract Type 1 diabetes is a chronic disease caused by autoimmune destruction of pancreatic β cells. Individuals with type 1 diabetes are reliant on insulin for survival. Despite enhanced knowledge related to the pathophysiology of the disease, including interactions between genetic, immune, and environmental contributions, and major strides in treatment and management, disease burden remains high. Studies aimed at blocking the immune attack on β cells in people at risk or individuals with very early onset type 1 diabetes show promise in preserving endogenous insulin production. This Seminar will review the field of type 1 diabetes, highlighting recent progress within the past 5 years, challenges to clinical care, and future directions in research, including strategies to prevent, manage, and cure the disease.
    MeSH term(s) Humans ; Diabetes Mellitus, Type 1/drug therapy ; Insulin/therapeutic use ; Insulin-Secreting Cells
    Chemical Substances Insulin
    Language English
    Publishing date 2023-04-05
    Publishing country England
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural
    ZDB-ID 3306-6
    ISSN 1474-547X ; 0023-7507 ; 0140-6736
    ISSN (online) 1474-547X
    ISSN 0023-7507 ; 0140-6736
    DOI 10.1016/S0140-6736(23)00223-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: PD-1 and CTLA4: Two checkpoints, one pathway?

    Walker, Lucy S K

    Science immunology

    2017  Volume 2, Issue 11

    Language English
    Publishing date 2017-04-21
    Publishing country United States
    Document type Journal Article
    ISSN 2470-9468
    ISSN 2470-9468
    DOI 10.1126/sciimmunol.aan3864
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Editorial: Control of Regulatory T Cell Stability, Plasticity, and Function in Health and Disease.

    Piconese, Silvia / Walker, Lucy S K / Dominguez-Villar, Margarita

    Frontiers in immunology

    2021  Volume 11, Page(s) 611591

    MeSH term(s) Animals ; Cardiovascular Diseases/immunology ; Cardiovascular Diseases/metabolism ; Cardiovascular Diseases/pathology ; Cell Differentiation ; Cell Lineage ; Cell Plasticity ; Cellular Microenvironment ; Colorectal Neoplasms/immunology ; Colorectal Neoplasms/metabolism ; Colorectal Neoplasms/pathology ; Humans ; Inflammation/immunology ; Inflammation/metabolism ; Inflammation/pathology ; Phenotype ; T-Lymphocytes, Regulatory/immunology ; T-Lymphocytes, Regulatory/metabolism ; T-Lymphocytes, Regulatory/pathology
    Language English
    Publishing date 2021-01-27
    Publishing country Switzerland
    Document type Editorial ; Introductory Journal Article
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2020.611591
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The immunology of type 1 diabetes.

    Herold, Kevan C / Delong, Thomas / Perdigoto, Ana Luisa / Biru, Noah / Brusko, Todd M / Walker, Lucy S K

    Nature reviews. Immunology

    2024  

    Abstract: Following the seminal discovery of insulin a century ago, treatment of individuals with type 1 diabetes (T1D) has been largely restricted to efforts to monitor and treat metabolic glucose dysregulation. The recent regulatory approval of the first ... ...

    Abstract Following the seminal discovery of insulin a century ago, treatment of individuals with type 1 diabetes (T1D) has been largely restricted to efforts to monitor and treat metabolic glucose dysregulation. The recent regulatory approval of the first immunotherapy that targets T cells as a means to delay the autoimmune destruction of pancreatic β-cells highlights the critical role of the immune system in disease pathogenesis and tends to pave the way for other immune-targeted interventions for T1D. Improving the efficacy of such interventions across the natural history of the disease will probably require a more detailed understanding of the immunobiology of T1D, as well as technologies to monitor residual β-cell mass and function. Here we provide an overview of the immune mechanisms that underpin the pathogenesis of T1D, with a particular emphasis on T cells.
    Language English
    Publishing date 2024-02-02
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2062776-2
    ISSN 1474-1741 ; 1474-1733
    ISSN (online) 1474-1741
    ISSN 1474-1733
    DOI 10.1038/s41577-023-00985-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Targeting T

    Yu, Di / Walker, Lucy S K / Liu, Zheng / Linterman, Michelle A / Li, Zhanguo

    Nature immunology

    2022  Volume 23, Issue 8, Page(s) 1157–1168

    Abstract: The identification of ... ...

    Abstract The identification of CD4
    MeSH term(s) Antibody Formation ; B-Lymphocytes ; Cell Differentiation ; Germinal Center ; Humans ; T-Lymphocytes, Helper-Inducer ; Vaccination
    Language English
    Publishing date 2022-07-11
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2016987-5
    ISSN 1529-2916 ; 1529-2908
    ISSN (online) 1529-2916
    ISSN 1529-2908
    DOI 10.1038/s41590-022-01253-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: EFIS Lecture: Understanding the CTLA-4 checkpoint in the maintenance of immune homeostasis.

    Walker, Lucy S K

    Immunology letters

    2017  Volume 184, Page(s) 43–50

    Abstract: The past 20 years have heralded fascinating developments in the field of CTLA-4 biology. The CTLA-4 protein is a critical negative regulator of T cell immunity and its absence provokes severe lymphoproliferative disease. In a surprising twist, the ... ...

    Abstract The past 20 years have heralded fascinating developments in the field of CTLA-4 biology. The CTLA-4 protein is a critical negative regulator of T cell immunity and its absence provokes severe lymphoproliferative disease. In a surprising twist, the generation of mixed bone marrow chimeric mice revealed that CTLA-4 predominantly functions in a cell-extrinsic manner, suggesting that CTLA-4 expressed on one cell can modify the behaviour of another cell. This was followed by the demonstration that CTLA-4 is highly expressed in regulatory T cells and can contribute to their suppressive activity. In line with a cell-extrinsic function, increasing evidence indicates that CTLA-4-positive cells can modify the phenotype of antigen presenting cells (APC), thereby regulating the priming of naive T cells. Notably, CTLA-4 is able to downregulate expression of costimulatory ligands on APC via a process of trans-endocytosis. The identification of patients with mutations in the ctla4 gene has provided an opportunity to study the contribution of CTLA-4 to Treg function and immune regulation in the human immune system. Finally, it has become apparent that CTLA-4 also plays a role in controlling humoral immunity, via the regulation of CD28-driven follicular helper T cell differentiation. At the recent German Society for Immunology congress, I discussed some of the contributions of my own lab to the unfolding of the CTLA-4 story, in the context of the work of others in the field. Despite the enormous clinical potential associated with modulation of the CTLA-4 pathway, including the use of soluble CTLA-4 molecules in autoimmune settings and blocking antibodies in cancer, it is clear there is still much to learn about this important pathway.
    MeSH term(s) Animals ; Antigen-Presenting Cells/immunology ; Antigen-Presenting Cells/metabolism ; Biomarkers ; CTLA-4 Antigen/deficiency ; CTLA-4 Antigen/genetics ; CTLA-4 Antigen/metabolism ; Cell Differentiation/genetics ; Cell Differentiation/immunology ; Endocytosis ; Homeostasis ; Humans ; Immunity ; Immunomodulation ; Lymphocyte Activation/immunology ; Signal Transduction ; T-Lymphocyte Subsets/cytology ; T-Lymphocyte Subsets/immunology ; T-Lymphocyte Subsets/metabolism ; T-Lymphocytes, Regulatory/immunology ; T-Lymphocytes, Regulatory/metabolism
    Chemical Substances Biomarkers ; CTLA-4 Antigen
    Language English
    Publishing date 2017-02-16
    Publishing country Netherlands
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 445150-8
    ISSN 1879-0542 ; 0165-2478
    ISSN (online) 1879-0542
    ISSN 0165-2478
    DOI 10.1016/j.imlet.2017.02.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Publisher Correction: Targeting co-stimulatory molecules in autoimmune disease.

    Edner, Natalie M / Carlesso, Gianluca / Rush, James S / Walker, Lucy S K

    Nature reviews. Drug discovery

    2020  Volume 20, Issue 1, Page(s) 82

    Language English
    Publishing date 2020-11-18
    Publishing country England
    Document type Published Erratum
    ZDB-ID 2062954-0
    ISSN 1474-1784 ; 1474-1776
    ISSN (online) 1474-1784
    ISSN 1474-1776
    DOI 10.1038/s41573-020-00116-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Dimers Aren't Forever: CD80 Breaks up with PD-L1.

    Sansom, David M / Walker, Lucy S K

    Immunity

    2020  Volume 51, Issue 6, Page(s) 972–974

    Abstract: Targeting the CTLA-4 and PD-1 "checkpoints" is an effective treatment for a number of cancers. In this issue of Immunity, Hui et al. reveal that interaction between a CTLA-4 ligand, CD80, and its counterpart in the PD-1 pathway, PD-L1, affects both PD-1 ... ...

    Abstract Targeting the CTLA-4 and PD-1 "checkpoints" is an effective treatment for a number of cancers. In this issue of Immunity, Hui et al. reveal that interaction between a CTLA-4 ligand, CD80, and its counterpart in the PD-1 pathway, PD-L1, affects both PD-1 and CTLA-4 function, raising new questions about the biological effects of using checkpoint inhibitors alone and in combination.
    MeSH term(s) B7-1 Antigen ; B7-H1 Antigen ; CD28 Antigens ; CTLA-4 Antigen ; Programmed Cell Death 1 Receptor
    Chemical Substances B7-1 Antigen ; B7-H1 Antigen ; CD28 Antigens ; CTLA-4 Antigen ; Programmed Cell Death 1 Receptor
    Language English
    Publishing date 2020-01-07
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 1217235-2
    ISSN 1097-4180 ; 1074-7613
    ISSN (online) 1097-4180
    ISSN 1074-7613
    DOI 10.1016/j.immuni.2019.11.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top